• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Metagenomic Sequencing Boosts Pathogen Detection but Yields Low Specificity in Sepsis

by
November 19, 2026
in Health
Reading Time: 7 mins read
0
Metagenomic Sequencing Boosts Pathogen Detection but Yields Low Specificity in Sepsis

Metagenomic Sequencing Boosts Pathogen Detection but Yields Low Specificity in Sepsis

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A retrospective cohort investigation examining adult intensive care unit patients with sepsis found that metagenomic next-generation sequencing substantially expanded the recovery of causative pathogens compared with conventional microbiological testing, although it demonstrated a notably low diagnostic specificity against an adjudicated clinical reference standard. Conducted at the First Affiliated Hospital of Fujian Medical University between January 2022 and September 2024, the study evaluated paired clinical specimens from 162 patients meeting Sepsis-3 diagnostic criteria, which require suspected or confirmed infection alongside an acute increase in the Sequential Organ Failure Assessment score of two or more points. In this cohort, metagenomic sequencing identified microbial nucleic acids in 81.37 percent of patients, whereas conventional culture and smear testing yielded a positive finding in 56.17 percent. However, when evaluated against a composite clinical diagnosis established by independent physician review, the genomic platform exhibited a diagnostic sensitivity of 92.55 percent paired with a specificity of only 35.29 percent, highlighting ongoing difficulties in distinguishing active infectious etiologies from biological colonizers, latent viral presence, and background environmental signals.

Sepsis remains a formidable clinical challenge across critical care medicine, characterized by rapid systemic deterioration, progressive multiorgan failure, and substantial inpatient mortality. Standard care mandates the rapid administration of effective antimicrobial agents, yet clinicians frequently rely on empirical broad-spectrum regimens because conventional cultures take several days to grow or fail entirely when patients have received prior antibiotics. Conventional microbiological testing primarily involves automated broth cultures, solid agar plating, and smear microscopy, modalities that exhibit documented limitations when encountering slow-growing, fastidious, intracellular, or low-burden microorganisms. In contrast, metagenomic next-generation sequencing bypasses the necessity for viable cell proliferation by extracting total DNA and RNA directly from patient body fluids. By generating millions of sequence reads and comparing them against comprehensive microbial genomic databases, the method allows for hypothesis-free identification of bacteria, fungi, viruses, and parasites within a single analytical workflow, offering particular utility for critically ill individuals presenting with complex or culture-negative infection profiles.

The demographic and clinical profile of the analyzed cohort underscores the severe illness burden typical of medical and surgical intensive care environments. Among the 162 enrolled participants, the median age was 68 years, with an interquartile range spanning 57 to 74 years, and male patients comprised 67.90 percent of the study group. Chronic comorbid conditions were highly prevalent, led by hypertension in 39.51 percent, diabetes mellitus in 24.07 percent, chronic pulmonary disease in 13.58 percent, and chronic kidney disease in 12.96 percent. Furthermore, 38.89 percent of the patients were formally classified as immunocompromised due to underlying hematologic malignancies, active chemotherapy regimens for solid organ tumors, systemic autoimmune disorders receiving biological or glucocorticoid immunosuppression, or severe baseline cytopenias. At the time of intensive care unit admission, the cohort presented with a median Sequential Organ Failure Assessment score of 7 and a median Acute Physiology and Chronic Health Evaluation II score of 19. A total of 130 patients, representing 80.25 percent of the cohort, required invasive mechanical ventilation, and overall in-hospital mortality reached 52.47 percent.

A critical characteristic of the study design involves the distribution of biological specimen types submitted for matched analysis. Bronchoalveolar lavage fluid accounted for 66.05 percent of all examined samples, followed by peripheral blood at 19.14 percent, cerebrospinal fluid at 10.49 percent, and sputum or other sterile fluid collections in the remainder. Because lower respiratory tract fluids represented nearly two-thirds of all diagnostic materials, the authors emphasized that the observed clinical dynamics primarily reflect severe pulmonary infections and ventilator-associated lower airway disease rather than systemic sepsis arising from diverse intra-abdominal, urological, or soft-tissue foci. Sampling protocols required simultaneous collection or acquisition within a 48-hour window from the same anatomical site, with one aliquot processed immediately through institutional laboratory medicine workflows and the second sent to an accredited genomics reference laboratory for high-throughput sequencing. Peripheral blood was reserved for cases where localized primary sampling was impossible or the primary anatomic source remained clinically indeterminate.

Laboratory procedures for the conventional arm adhered to standard hospital diagnostic workflows, utilizing automated blood culture instruments with extended incubation times of 5 to 6 days for aerobic bottles and up to 14 days for anaerobic bottles. Respiratory secretions and body fluids were inoculated onto sheep blood agar and chocolate agar under controlled atmospheric conditions for up to 72 hours, with selective Sabouraud dextrose agar used for fungal cultures and Lowenstein-Jensen or liquid media monitored up to eight weeks when mycobacterial disease was suspected. Microbial identification and automated susceptibility testing were executed via matrix-assisted laser desorption ionization time-of-flight mass spectrometry and automated phenotypic analysis cards. Routine conventional protocols did not include systematic viral isolation. In parallel, metagenomic workflows extracted total nucleic acids using magnetic bead kits supplemented by mechanical bead-beating and enzymatic disruption to lyse rigid microbial cell walls, followed by library preparation, human sequence depletion, and sequencing on automated platforms, with secondary RNA sequencing performed in 22.2 percent of cases presenting high clinical suspicion for viral respiratory involvement.

The comparative diagnostic yield revealed substantial discrepancies across microbial kingdoms. Metagenomic testing identified 47 distinct pathogenic species, compared with 25 recognized by conventional culture. The marked overall yield advantage observed with sequencing was driven almost entirely by bacterial detection, which reached 74.07 percent with sequencing versus 40.12 percent by culture, reflecting high statistical significance. Metagenomic sequencing captured key hospital-acquired pathogens including Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia, while demonstrating exclusive identification of fastidious and atypical bacteria such as Legionella pneumophila, Chlamydia psittaci, Leptospira species, and Rickettsia. Conversely, total fungal detection rates between the two testing modalities showed no statistically significant difference, standing at 27.78 percent for sequencing and 20.37 percent for culture. Nevertheless, sequencing identified specific fungal pathogens that conventional media failed to grow, including 16 cases of Pneumocystis jirovecii, four detections of Cryptococcus, and three instances of Trichosporon asahii.

To evaluate diagnostic accuracy beyond pure culture comparison, the researchers utilized a consensus clinical reference standard formulated by two independent senior specialists in critical care and infectious disease. Evaluating physical symptoms, laboratory markers, serial radiological imaging, antimicrobial responses, and microbiological reports, the adjudicators assigned each detected organism into one of four categories: definite, probable, possible, or non-pathogenic, with only the first two designations deemed true causative agents. Against this composite standard, sequencing showed 92.55 percent sensitivity and 35.29 percent specificity, whereas agreement between the two tests yielded a modest kappa coefficient of 0.301. When conventional culture was treated as an alternative reference, sequencing sensitivity declined to 80.22 percent and specificity was 38.03 percent, with a lower kappa value of 0.190. Among 87 patients in whom both modalities produced positive findings, identical species-level concordance occurred in only 18.4 percent, partial concordance sharing at least one common organism occurred in 63.2 percent, and completely discordant organism lists were observed in the remaining 18.4 percent.

Descriptive subgroup analyses of immunocompromised participants highlighted the broad breadth of opportunistic pathogens detectable through genomic screening. Although raw detection rates for Pneumocystis jirovecii, herpes simplex virus types 1 and 2, and cytomegalovirus were numerically higher among immunocompromised patients, these exploratory comparisons across 35 distinct taxonomic categories did not retain statistical significance after applying the Benjamini-Hochberg false discovery rate correction for multiple testing. Viral sequences, which were detected exclusively by metagenomic sequencing due to the lack of routine conventional viral isolation, were noted in substantial numbers across the cohort. However, of 192 total viral sequence signatures registered by sequencing instruments, only 57 were adjudicated as clinically contributory pathogens following detailed medical record review. The investigators noted that distinguishing benign viral shedding, oropharyngeal colonization, and latent reactivation of herpesviruses from active systemic disease poses a major interpretive challenge in critical care settings.

Treating clinicians adopted metagenomic sequencing reports to guide patient management in 131 out of 162 cases, representing an 80.9 percent clinical adoption rate. These genomic findings directly informed targeted antimicrobial adjustments in 80 individuals, justified regimen de-escalation in 8 patients, and supported the continuation of empirical regimens in 43 patients. Secondary physiological markers measured one week after specimen acquisition demonstrated that median white blood cell counts declined by 1.17 times ten to the ninth cells per liter in the adoption group, representing a significantly greater drop compared to the non-adopted group, while decreases in C-reactive protein and procalcitonin showed no statistically significant differences between groups. Furthermore, changes in organ failure scores evaluated three to four days following treatment modification did not differ significantly between groups, with both the adopted and non-adopted cohorts demonstrating a median reduction of one point in Sequential Organ Failure Assessment scores.

In the primary survival analysis of the full 162-patient cohort, clinical adoption of metagenomic sequencing findings was associated with a statistically significant reduction in 28-day mortality, recording an unadjusted death rate of 38.16 percent in the adopted group versus 58.06 percent in the non-adopted group. After multivariable Cox proportional-hazards regression adjusting for baseline age, sex, underlying comorbidities, disease severity indices, and mechanical ventilation, adoption retained an independent statistical association with survival, yielding an adjusted hazard ratio of 0.53 with a 95 percent confidence interval spanning 0.30 to 0.92. However, the non-adopted comparison arm contained five critically ill patients who died or were discharged against medical advice before metagenomic sequencing test results could be delivered to the bedside. When researchers performed a prespecified sensitivity analysis excluding these five individuals who never had an opportunity to receive sequence-guided intervention, the 28-day mortality difference attenuated, resulting in an adjusted hazard ratio of 0.65 with a 95 percent confidence interval of 0.34 to 1.23, which was no longer statistically significant.

The study authors identified several structural limitations that warrant careful interpretation of the empirical findings. The single-center retrospective format inherently limits causal inference and restricts statistical power within smaller clinical subgroups. Moreover, the composite diagnostic benchmark incorporated sequencing findings during clinical case reviews, introducing incorporation bias that may overestimate true diagnostic sensitivity while penalizing specificity. Prior antibiotic exposure in nearly all participants likely suppressed bacterial recovery in culture media while leaving non-viable microbial DNA intact for sequencing instruments, potentially exaggerating the comparative detection advantage. Given the heavy predominance of bronchoalveolar lavage specimens, the risk of detecting non-pathogenic airway colonizers remains prominent, emphasizing that broad molecular detection cannot be equated with acute disease causation. The investigators concluded that while metagenomic sequencing provides valuable etiological clarity for fastidious, atypical, and complex infections in the intensive care unit, its definitive impact on patient survival and antimicrobial stewardship must be validated through prospective, randomized clinical trials.

Subject of Research: Metagenomic next-generation sequencing for pathogen identification and antimicrobial guidance in intensive care unit sepsis patients

Article Title: Metagenomic next-generation sequencing for pathogen detection and management in ICU patients with sepsis

Article References: Jiang, Q., Hong, W., & Lin, X. (2026). Metagenomic next-generation sequencing for pathogen detection and management in ICU patients with sepsis. Frontiers in Cellular and Infection Microbiology, 16, 1907014. https://doi.org/10.3389/fcimb.2026.1907014

Image Credits: AI Generated

DOI: 10.3389/fcimb.2026.1907014

Keywords: metagenomic next-generation sequencing, sepsis, intensive care unit, pathogen detection, conventional microbiological testing, bronchoalveolar lavage fluid, antimicrobial stewardship, diagnostic specificity, diagnostic sensitivity, opportunistic infections, bacterial infections, fungal infections, immunocompromised patients, critical care medicine, retrospective cohort study, mortality outcomes, clinical microbiology

News Source: Kristina Jarvis. (November 19, 2026). Metagenomic Sequencing Boosts Pathogen Detection but Yields Low Specificity in Sepsis. Scienmag.

Tags: Antimicrobial StewardshipBacterial infectionsbronchoalveolar lavage fluidclinical microbiologyconventional microbiological testingcritical care medicinediagnostic sensitivitydiagnostic specificityfungal infectionsimmunocompromised patientsintensive care unitmetagenomic next-generation sequencingmortality outcomesopportunistic infectionspathogen detectionretrospective cohort studysepsis
Share12Tweet7Share2ShareShareShare1

Related Posts

Clinicians Propose Framework to Protect Medicaid Care Amid Projected Federal Cuts

Clinicians Propose Framework to Protect Medicaid Care Amid Projected Federal Cuts

November 20, 2026
Caspofungin and Clindamycin-Primaquine Show Similar Mortality in Refractory Pneumocystis Pneumonia

Caspofungin and Clindamycin-Primaquine Show Similar Mortality in Refractory Pneumocystis Pneumonia

November 20, 2026

BADF-Net Outperforms Eleven Baseline Models in Segmenting Abdominal Ultrasound Structures

November 20, 2026

Study Finds Blood-Borne Pathogen Knowledge Gaps Among Yemeni Health Sciences Students

November 20, 2026

POPULAR NEWS

  • CMOS Potts Chip Harnesses Multiphase Oscillations for Low-Power Memory and Graph Optimization

    CMOS Potts Chip Harnesses Multiphase Oscillations for Low-Power Memory and Graph Optimization

    29 shares
    Share 12 Tweet 7
  • Optimized Radiolabeling Improves iPSMA Homogeneity and Supports Single Vial Cold Kit Formulation

    29 shares
    Share 12 Tweet 7
  • Cross-Sectional Bahrain Survey Links Weather, Demands, and Gender to Activity Rates

    29 shares
    Share 12 Tweet 7
  • Biologists Propose Teleonome Framework to Assess Animal Welfare and Agency

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Electrosprayed Starch Microparticles Stabilize Blackberry Extract and Protect Bioactive Antioxidants

Clinicians Propose Framework to Protect Medicaid Care Amid Projected Federal Cuts

Plant-Disjoint Audit Shows High Accuracy in Automated Coconut Disease Recognition Model

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.